Vincerx Pharma, Inc.
Vincerx Pharma, Inc. (VINC) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · VINC · as of Jun 9, 2026
Key Statistics
Explore Vincerx Pharma, Inc. Data
vinc stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 7 · Buy rate: 100.0%
The VINC analyst consensus is Buy, based on ratings from 7 Wall Street analysts over the past 3 months. The average 12-month price target is $3.00, representing +22713.69% upside from the current price of $0.01.
Competitors & Peers
vinc competitorsVINC
ACON
DRMA
FOXO
PIII
PPBTStock Performance
Full HistoryAbout Vincerx Pharma, Inc.
Vincerx Pharma, Inc. is a biopharmaceutical firm currently in the clinical development phase, dedicated to discovering and advancing innovative treatments for cancer, specifically addressing areas of …
what is vincerx pharma, inc. · vinc stock overview · vincerx pharma, inc. company profile · who is vincerx pharma, inc. ceo · vinc OTC · vincerx pharma, inc. headquarters · vincerx pharma, inc. business segments
About Stock Overview & Key Data
Vincerx Pharma, Inc. (VINC) is a Healthcare company in the Biotechnology industry, listed on OTC since May 27, 2020. As of the latest trading session, VINC stock price is $0.01, with a market capitalization of $68,831. The stock has returned -74.71% over the past 12 months and +1.15% year-to-date.
According to 7 Wall Street analysts, the consensus rating for Vincerx Pharma, Inc. stock is Buy, with an average 12-month price target of $3.00. In fiscal year 2024, Vincerx Pharma, Inc. reported revenue of — and net income of -$30.1M. For detailed data — including Vincerx Pharma, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Vincerx Pharma, Inc. (VINC) stock price is $0.01. The stock is traded on OTC under the ticker symbol VINC. The 52-week range is $0.00 – $1.43.